These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3216640)

  • 1. IGM nephropathy in childhood--is it a distinct entity?
    Yap HK; Murugasu B; Saw AH; Chiang GS
    J Singapore Paediatr Soc; 1988; 30(3-4):145-9. PubMed ID: 3216640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicopathological study of renal biopsy cases with predominant IgM deposition with particular reference to the disease entity, IgM nephropathy].
    Maeda S; Ishihara S; Kobayashi S; Yamada A; Migita T; Kitajima W; Kobayashi K; Nishiura T; Kawamura S; Tsujimoto S
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1399-409. PubMed ID: 3820816
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
    Pardo V; Riesgo I; Zilleruelo G; Strauss J
    Am J Kidney Dis; 1984 Jan; 3(4):264-9. PubMed ID: 6691342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A histological study of idiopathic nephrotic syndrome--localization of IgM in the glomeruli].
    Akano N; Uraoka Y; Tohda M; Miyamoto H; Iseki T; Takemura T; Maki S
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):235-42. PubMed ID: 4021187
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there an IgM nephropathy?
    Murphy MJ; Bailey RR; McGiven AR
    Aust N Z J Med; 1983 Feb; 13(1):35-8. PubMed ID: 6576743
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Significance of 'focal sclerosis' in lipoid nephrosis.
    Elema JD
    Arch Dis Child; 1974 Jun; 49(6):497. PubMed ID: 4853850
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of mesangial IgM nephropathy into focal segmental glomerulosclerosis.
    Jennette JC
    Am J Nephrol; 1981; 1(3-4):222. PubMed ID: 7349055
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
    Looi LM; Wang F; Lam KL; Chua CT
    Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of predominant IgM deposition in glomerular diseases].
    Koshino Y; Kida H; Yokoyama H; Yoshimura M; Asamoto T; Saito Y; Tomosugi N; Abe T; Hattori N
    Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1293-300. PubMed ID: 6527428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mesangial IgM nephropathy].
    Zhang JH; Li LS
    Zhonghua Nei Ke Za Zhi; 1984 Mar; 23(3):141-4. PubMed ID: 6489005
    [No Abstract]   [Full Text] [Related]  

  • 12. IgA nephropathy in children.
    Yoshikawa N; Matsuo T
    Compr Ther; 1984 May; 10(5):35-41. PubMed ID: 6375943
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoid nephrosis. A multifold blind study, including quantitation.
    Kawano K; Wenzl J; McCoy J; Porch J; Kimmelstiel P
    Lab Invest; 1971 Jun; 24(6):499-503. PubMed ID: 5090999
    [No Abstract]   [Full Text] [Related]  

  • 14. Adult lipoid nephrosis: clinicopathological correlations.
    Lim VS; Sibley R; Spargo B
    Ann Intern Med; 1974 Sep; 81(3):314-20. PubMed ID: 4368384
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians.
    Donia AF; Sobh MA; Moustafa FE; Bakr MA; Foda MA
    J Nephrol; 2000; 13(4):275-81. PubMed ID: 10946807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histologic transition in patients with minimal-change nephrotic syndrome to mesangial IgM nephropathy].
    Claros González I; Baños Gallardo M; Forascepi Roza R; Argüelles Toraño M
    Rev Clin Esp; 1986 Dec; 179(9):476-7. PubMed ID: 3809684
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal change variants: IgM nephropathy.
    Matsukura H; Higuchi O; Arai M; Itoh Y; Miyawaki T
    Clin Nephrol; 2006 Feb; 65(2):147-9. PubMed ID: 16509468
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimal change nephropathy during gold treatment. A case with unusual histopathological and immunopathological features.
    Wolters J; Frederik P; van Rie H; Zeppenfeldt E
    Neth J Med; 1987 Dec; 31(5-6):234-40. PubMed ID: 3124008
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome.
    Vilches AR; Turner DR; Cameron JS; Ogg CS; Chantler C; Williams DG
    Lab Invest; 1982 Jan; 46(1):10-5. PubMed ID: 7054586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoid nephrosis: a reassessment.
    Jao W; Lewy P; Norris SH; Pollak VE; Pirani CL
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():183-98. PubMed ID: 4620918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.